(Q72308095)
Statements
The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome (English)
E Eriksson
M A Hedberg
B Andersch
scientific article published on 01 April 1995
No description defined